ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,0874
-0,15%
Bitcoin
66.310,06
-0,94%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Prevail Therapeutics Inc (PRVL)

  7. Prevail Therapeutics Inc (PRVL) News

PRVL

Prevail Therapeutics (PRVL)

Prevail Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRVL
DatumZeitQuelleÜberschriftSymbolFirma
16/02/202122h43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
16/02/202122h36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
12/02/202122h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
12/02/202122h08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVLPrevail Therapeutics Inc
01/02/202112h41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRVLPrevail Therapeutics Inc
29/01/202122h16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRVLPrevail Therapeutics Inc
29/01/202112h13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRVLPrevail Therapeutics Inc
27/01/202112h12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
26/01/202123h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202122h39Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202122h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202115h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202115h03Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202115h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRVLPrevail Therapeutics Inc
22/01/202114h55PR Newswire (US)Lilly Completes Acquisition of Prevail TherapeuticsNASDAQ:PRVLPrevail Therapeutics Inc
20/01/202113h01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVLPrevail Therapeutics Inc
20/01/202112h44Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRVLPrevail Therapeutics Inc
05/01/202114h29Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVLPrevail Therapeutics Inc
05/01/202113h55Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRVLPrevail Therapeutics Inc
22/12/202014h50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRVLPrevail Therapeutics Inc
22/12/202014h34Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVLPrevail Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PRVL

Kürzlich von Ihnen besucht

EU
Y148S
Y148S
AMEX
TSLH
Innovator Hedged TSLA St...
BITV
LUNA2EUR
Terra
USOTC
KYMCF
Kyoritsu Maintenance (PK)
BIT
UI565A
Unicredit Bank
NASDAQ
ARQT
Arcutis Biotherapeutics
LSE
CLON
Clontarf Energy
EU
MTU
Manitou BF
COIN
DTCOUSD
BIT
S28666
Societe Generale Effekten
EU
WHA
Wereldhave NV
NYSE
LSGR
Natixis ETF Trus
AMEX
PWZ
Invesco California AMTFr...
EU
9382T
9382T
USOTC
ASZCF
COIN
SUPBTC
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten